Bacterial vaginosis (BV) and Trichomonas vaginalis (TV) co-infection, and bacterial antibiogram profile of pregnant women studied in Lagos, Nigeria.
Humans
Female
Vaginosis, Bacterial
/ epidemiology
Nigeria
/ epidemiology
Adult
Cross-Sectional Studies
Pregnancy
Coinfection
/ epidemiology
Trichomonas vaginalis
/ drug effects
Trichomonas Vaginitis
/ epidemiology
Young Adult
Anti-Bacterial Agents
/ pharmacology
Microbial Sensitivity Tests
Pregnancy Complications, Infectious
/ epidemiology
Prevalence
Adolescent
Trichomonas vaginalis
Antenatal
Antibacterial profile
Bacterial vaginosis
Co-infection
Nigeria
Pregnant women
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
23 Jul 2024
23 Jul 2024
Historique:
received:
04
12
2023
accepted:
10
07
2024
medline:
23
7
2024
pubmed:
23
7
2024
entrez:
22
7
2024
Statut:
epublish
Résumé
This study was undertaken to determine the prevalence of Bacterial Vaginosis (BV), Trichomonas Vaginalis (TV) co-infection, and the antibacterial sensitivity profile of bacterial isolates. The study was a cross-sectional study of 232 pregnant women on a routine antenatal visit between April 2019 and Sept. 2020, at Amukoko clinic in Lagos, Nigeria. The gynaecologist conducted the clinical examination on each patient looking for vaginal discharge and its consistency/homogeneity, colour and odour. Two High Vaginal Swab (HVS) samples were taken from every patient and a semi-structured questionnaire was used to gather the socio-demographic, practices/attitudes, and clinical information of each participant. One sample was employed for wet preparation to identify the TV and BV diagnosis using Amsel's criteria and Whiff's test. The second sample was used for bacterial culture and antibiogram was conducted using the disc diffusion technique. The Clinical Laboratory Standard Institutes' (CLSI) interpretative criteria were used to categorise the results. The mean age of the clients was 28.11 ± 7.08 years of age. The majority (88%) were aged 15-35 years. Only 81 (34.9%) had microbial organisms isolated or seen from their specimens and 19 (8.2%) of such were classified as having BV (Bacteriods or Gardnerella isolated). Of the 81 infected, 33 (40.8%) had only bacterial infection, 36 (44.4%) had TV alone and 12 (14.8%) had bacteria co-infected with TV. From the clinical records, the population that was classified as having UTI or vaginitis was only 46 (20.7%) The study observed age (15-35 years) related association between vaginosis/ TV co-infection (X There is a relatively low prevalence of BV and flagellate co-infection in the community studied. We recommend screening of antenatal women with underlying symptoms for BV and flagellates co-infection to avoid its progression to vaginitis.
Identifiants
pubmed: 39039485
doi: 10.1186/s12905-024-03257-y
pii: 10.1186/s12905-024-03257-y
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
415Informations de copyright
© 2024. The Author(s).
Références
Lin P, et al. Vaginal PH value for clinical diagnosis and treatment of common vaginitis. Diagnostics. 2021;11(11):1996. https://doi.org/10.3390/diagnostics1111199 .
doi: 10.3390/diagnostics1111199
pubmed: 34829343
pmcid: 8618584
Hillier S, Holmes K, et al. Bacterial vaginosis. In: Holmes K, Sparling P, Mardh P, et al., editors. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill; 1999. p. 563–86.
Centers for Disease Control and Prevention. Trichomoniasis – CDC fact sheet. 2017. https://www.cdc.gov/std/trichomonas/STDFact-Trichomoniasis.htm .
USPSTF (US Preventive Services Task Force). Screening for bacterial vaginosis in pregnant persons to prevent preterm delivery: US Preventive Services Task Force recommendation statement. JAMA. 2020;323(13):1286–92. https://doi.org/10.1001/jama.2020.2684 .
doi: 10.1001/jama.2020.2684
Muzny CA, Sobel JD. The role of antimicrobial resistance in refractory and recurrent bacterial vaginosis and current recommendations for treatment. Antibiotics. 2022;11:500. https://doi.org/10.3390/antibiotics11040500 .
doi: 10.3390/antibiotics11040500
pubmed: 35453251
pmcid: 9024683
Workowski KA, Bachmann LH, Chang PA, et al. Sexually transmitted infections treatment guidelines. MMWR Recomm Rep. 2021;70(4):1–187.
doi: 10.15585/mmwr.rr7004a1
pubmed: 34292926
pmcid: 8344968
Centers for Disease Control and Prevention. STDs & pregnancy—CDC fact sheet. 2011. Retrieved March 28, 2012, from https://www.cdc.gov/std/pregnancy/STDFact-Pregnancy.htm .
AbouChacra L, Fenollar F, Diop K. Bacterial vaginosis: what do we currently know? Front Cell Infect Microbiol. 2022;11:672429. https://doi.org/10.3389/fcimb.2021.672429 . Published 2022 Jan 18.
doi: 10.3389/fcimb.2021.672429
CDC Facts & Brochures, 2021 The Facts - Trichomoniasis ( cdc.gov ).
McGregor JA, French JI. Bacterial vaginosis in pregnancy. Obstet Gynecol Surv. 2000;55(5 Suppl 1):S1-19. https://doi.org/10.1097/00006254-200005001-00001 . PMID: 10804540.
doi: 10.1097/00006254-200005001-00001
pubmed: 10804540
Schumann JA, Plasner S. Trichomoniasis. [Updated 2023 Jun 12]. In: StatPearls. Treasure Island: StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534826/ .
Griffiths EC, Pedersen AB, et al. The nature and consequences of co-infection in humans. J Infect. 2011;63(3):200–6. https://doi.org/10.1016/j.jinf.2011.06.005 . Accessed 19 Mar 2023.
doi: 10.1016/j.jinf.2011.06.005
pubmed: 21704071
pmcid: 3430964
Loveless M, Myint O. Vulvovaginitis- presentation of more common problems in pediatric and adolescent gynecology. Best Pract Res Clin Obstet Gynaecol. 2018;48:14–27. https://doi.org/10.1016/j.bpobgyn.2017.08.014 .
doi: 10.1016/j.bpobgyn.2017.08.014
pubmed: 28927766
Mirmonsef P, et al. The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract. Curr HIV Res. 2012;10(3):202. https://doi.org/10.2174/157016212800618165 . Accessed 23 Nov 2023.
doi: 10.2174/157016212800618165
pubmed: 22384839
pmcid: 3788616
Threstha S. Ecology and evolution of host-pathogen interactions in nature. Am Nat. 2011;164(S5):S1–5. https://www.jstor.org/stable/10.1086/424611 .
Knezevic A, Stepanovic S, Cypic M, Jevtovic D, Ranin J, Jovanovic T. Reduced quantity and hydrogen-peroxide production of vaginal lactobacilli in HIV positive women. Biomed Pharmacother. 2005;59(9):521–3.
doi: 10.1016/j.biopha.2005.06.010
pubmed: 16271844
Kalia N, Singh J, Kaur M. Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review. Ann Clin Microbiol Antimicrob. 2020;19:5. https://doi.org/10.1186/s12941-020-0347 .
doi: 10.1186/s12941-020-0347
pubmed: 31992328
pmcid: 6986042
Fooladi AAI, Khani S, Hosseini HM, et al. Impact of altered early infant gut microbiota following breastfeeding and delivery mode on allergic diseases. Inflamm Allergy Drug Targets. 2013;12(6):410–8.
doi: 10.2174/1871528112666131205113129
pubmed: 24304331
Africander D, Louw R, Verhoog N, et al. Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract. Contraception. 2011;84(4):423–35.
doi: 10.1016/j.contraception.2011.06.006
pubmed: 21920200
Hillebrand L, Harmanli OH, Whiteman V, Khandelwal M. Urinary tract infections in pregnant women with bacterial vaginosis. Am J Obstet Gynecol. 2002;186(5):916–7. https://doi.org/10.1067/mob.2002.123987 . PMID: 12015512.
doi: 10.1067/mob.2002.123987
pubmed: 12015512
Donders GG, Van Calsteren K, Bellen G, Reybrouck R, Vanden Bosch T, Riphagen I, et al. Predictive value for pretermbirth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG. 2009;116(10):1315–24.
doi: 10.1111/j.1471-0528.2009.02237.x
pubmed: 19538417
World Health Organistion. Global prevalence of incidence of selected curable sexually transmitted infections. 2001. (who.int) .
Bowden FJ, Garnet GP. Trichomonas vaguinalis epidemiology parametising and analyzing a model of treatment intervention. Sex Transm Infect. 2000;76:248–56.
doi: 10.1136/sti.76.4.248
pubmed: 11026878
pmcid: 1744187
Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas RV. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis. 2019;46(5):304–11. https://doi.org/10.1097/OLQ.0000000000000972 .
doi: 10.1097/OLQ.0000000000000972
pubmed: 30624309
Bhakta V, Aslam S, Aljaghwani A. Bacterial vaginosis in pregnancy: prevalence and outcomes in a tertiary care hospital. Afr J Reprod Health. 2021;25(1):49–55. https://doi.org/10.29063/ajrh2021/v25i1.6 .
doi: 10.29063/ajrh2021/v25i1.6
pubmed: 34077110
Afolabi BB, Moses EO, Oduyebo OO. Bacterial vaginosis and pregnancy outcome in Lagos, Nigeria. Open Forum Infect Dis. 2016;3(1):30.
doi: 10.1093/ofid/ofw030
Oyinloye MA, Olamiju IO, Popoola OO. Urban renewal strategies in developing nations: a focus on Amukoko, Lagos State, Nigeria. J Geogr Reg Plann. 2017;10(8):229–41.
doi: 10.5897/JGRP2017.0631
Charonis G, Larsson PG. Use of pH/whiff test or QuickVue advanced pH and amines test for the diagnosis of bacterial vaginosis and prevention of postabortion pelvic inflammatory disease. Acta Obstet Gynecol Scand. 2006;85(7):837–43. https://doi.org/10.1080/00016340600589776 .
doi: 10.1080/00016340600589776
pubmed: 16817083
Cheesbrough M. District laboratory practice in tropical countries part 1. 2nd ed. Cambridge: Cambridge University Press; 2009. p. 207–66.
Clinical Laboratory Standard Institute (CLSI). M100: performance standards for antimicrobial susceptibility testing, 27th edition. clsi.org; 2017, WEB500 1ST AVE. PITTSBURGH, PA 15219, USA.
Sobel JD. Bacterial vaginosis. Annu Rev Med. 2000;51:349–55.
doi: 10.1146/annurev.med.51.1.349
pubmed: 10774469
WHO. Women of reproductive age (15-49 years) population (thousands). 2023. https://www.who.int/data/gho/indicator-metadata-registry/imr-details/women-of-reproductive-age-(15-49-years) .
Udeogu, et al. Prevalence of bacterial vaginosis in pregnant women attending Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria using the complete Amsel’s diagnostic criteria. Afr J Clin Exper Microbiol. 2022;23(3):311–7.
doi: 10.4314/ajcem.v23i3.10
Konadu et al. BMC Pregnancy Childbirth. 2019;19:341. https://doi.org/10.1186/s12884-019-2488-z .
Sena AC, et al. Bacterial vaginosis and its association with incident Trichomonas vaginalis infections: a systematic review and meta-analysis. Sex Transm Dis. 2021;48(12):e192. https://doi.org/10.1097/OLQ.0000000000001537 . Accessed 16 Oct 2023.
doi: 10.1097/OLQ.0000000000001537
pubmed: 34433796
pmcid: 8594503
Roth AM, Williams JA, Ly R, et al. Changing sexually transmitted infection screening protocol will result in improved case finding for Trichomonas vaginalis among high-risk female populations. Sex Transm Dis. 2011;38:398–400.
doi: 10.1097/OLQ.0b013e318203e3ce
pubmed: 21217417
Squire DS, et al. Trichomonas vaginalis infection in southern Ghana: clinical signs associated with the infection. Trans R Soc Trop Med Hyg. 2019;113(7):359–69.
doi: 10.1093/trstmh/trz019
pubmed: 30989196
Barbosa S, et al. Prevalence and factors associated with Trichomonas vaginalis infection in indigenous Brazilian women. PLoS One. 2020;15(10):e0240323. https://doi.org/10.1371/journal.pone.0240323 . Accessed 16 Oct 2023.
doi: 10.1371/journal.pone.0240323
pubmed: 33064733
pmcid: 7567381
Mercer F, Johnson PJ. Trichomonas vaginalis: pathogenesis, symbiont interactions, and host cell immune responses. Trends Parasitol. 2018;34(8):683–93. https://doi.org/10.1016/j.pt.2018.05.006 . Accessed 24 Mar 2023.
doi: 10.1016/j.pt.2018.05.006
pubmed: 30056833
pmcid: 11132421
Govender Y, Chan T, Yamamoto HS, Budnik B, Fichorova RN. The role of small extracellular vesicles in viral-protozoan symbiosis: lessons from Trichomonasvirus in an isogenic host parasite model. Front Cell Infect Microbiol. 2020;10:591172. https://doi.org/10.3389/fcimb.2020.591172 . Published 2020 Nov 5.
doi: 10.3389/fcimb.2020.591172
pubmed: 33224901
pmcid: 7674494
Muzny CA, Sunesara IR, Martin DH, Mena LA. Sexually transmitted infections and risk behaviors among African American women who have sex with women: does sex with men make a difference? Sex Transm Dis. 2011;38(12):1118–25. https://doi.org/10.1097/OLQ.0b013e31822e6179 .
doi: 10.1097/OLQ.0b013e31822e6179
pubmed: 22082722
Huang Y, et al. Multiple sexual partners and vaginal microecological disorder are associated with HPV infection and cervical carcinoma development. Oncol Lett. 2020;20(2):1915–21. https://doi.org/10.3892/ol.2020.11738 . Accessed 19 Oct 2023.
doi: 10.3892/ol.2020.11738
pubmed: 32724435
pmcid: 7377087
Muzny CA, Taylor CM, Swords WE, Tamhane A, Chattopadhyay D, Cerca N, Schwebke JR. An updated conceptual model on the pathogenesis of bacterial vaginosis. J Infect Dis. 2019;220:1399–405.
doi: 10.1093/infdis/jiz342
pubmed: 31369673
pmcid: 6761952
Swidsinski A, Doerffel Y, Loening-Baucke V, Swidsinski S, Verstraelen H, Vaneechoutte M, Lemm V, Schilling J, Mendling W. Gardnerella biofilm involves females and males and is transmitted sexually. Gynecol Obstet Investig. 2010;70:256–63.
doi: 10.1159/000314015
Muzny CA, Schwebke JR. Gardnerella vaginalis: still a prime suspect in the pathogenesis of bacterial vaginosis. Curr Infect Dis Rep. 2013;15:130–5.
doi: 10.1007/s11908-013-0318-4
pubmed: 23371405
Onoh R, Umeora O, Egwuatu V, Ezeonu P, Onoh T. Antibiotic sensitivity pattern of uropathogens from pregnant women with urinary tract infection in Abakaliki, Nigeria. Infect Drug Resist. 2013;6:225–33. https://doi.org/10.2147/IDR.S46002 . Published 2013 Dec 2.
doi: 10.2147/IDR.S46002
pubmed: 24324344
pmcid: 3854917
Center for Disease Control (CDC). Sexually transmitted infections treatment guideline. 2021. https://www.cdc.gov/std/treatment-guidelines/references.htm .
Muzny CA, Laniewski P, Schwebke JR, Herbst-Kralovetz MM. Host-vaginal microbiota interactions in the pathogenesis of bacterial vaginosis. Curr Opin Infect Dis. 2020;33:59–65.
doi: 10.1097/QCO.0000000000000620
pubmed: 31789672
pmcid: 7265982
Mena KD, Gerba CP. Risk assessment of Pseudomonas aeruginosa in water. In: Whitacre D, editor. Reviews of environmental contamination and toxicology, vol. 201. Boston: Springer; 2009. https://doi.org/10.1007/978-1-4419-0032-6_3 .
doi: 10.1007/978-1-4419-0032-6_3
Crone S, Vives-Flórez M, Kvich L, et al. The environmental occurrence of Pseudomonas aeruginosa. APMIS. 2020;128(3):220–31. https://doi.org/10.1111/apm.13010 .
doi: 10.1111/apm.13010
pubmed: 31709616
Ibrahim D, Jabbour JF, Kanj SS. Current choices of antibiotic treatment for Pseudomonas aeruginosa infections. Curr Opin Infect Dis. 2020;33(6):464–73. https://doi.org/10.1097/QCO.0000000000000677 .
doi: 10.1097/QCO.0000000000000677
pubmed: 33148986
Bostwick DG, Woody J, Hunt C, Budd W. Antimicrobial resistance genes and modelling of treatment failure in bacterial vaginosis: clinical study of 289 symptomatic women. J Med Microbiol. 2016;65:377–86.
doi: 10.1099/jmm.0.000236
pubmed: 26887782
Raabe VN, Shane AL. Group B Streptococcus (Streptococcus agalactiae). Microbiol Spectr. 2019;7(2). https://doi.org/10.1128/microbiolspec.GPP3-0007-2018 . Accessed 23 Oct 2023.